DDReg pharma

Quailty Driven by Passion

All Category

Home » All Category » Page 6
US FDA Radiological Health Regulations

Navigating US Regulations in Radiological Health 

Radiological health involves the safe use of radiation in medical diagnosis, treatment, and industrial applications. Its goal is to minimize unnecessary radiation exposure for patients, healthcare workers, and the public. Regulation is critical for managing the risks of ionizing radiation (such as cancer risks from excessive exposure).  As we navigate through 2025, staying informed about […]

Navigating US Regulations in Radiological Health  Read More »

Role of Blockchain and IoT in Drug Development.

Evaluating the Role of Blockchain and IoT in Drug Development

The pharmaceutical industry is undergoing a significant transformation, driven by the need for innovation and efficiency in pharmaceutical drug development. Drug development is a resource-intensive process that can take 10–15 years and cost billions of dollars to bring a medicine to market. One important aspect is the clinical trials, which face many challenges, including data

Evaluating the Role of Blockchain and IoT in Drug Development Read More »

Project Management

Project Management to Overcome Leadership & Timeline Delays

Customer Requirement  A pharmaceutical company required timely delivery of high-quality project management services without delays. The key objectives of the project were:  Ensuring on-time and quality-driven execution of regulatory submissions  Maintaining consistent project direction despite leadership changes  Managing political and time pressures without compromising project timelines  Ensuring timely submission of required documents from external stakeholders 

Project Management to Overcome Leadership & Timeline Delays Read More »

South Koreas Regulatory Landscape for drugs

Navigating the Drug Regulatory Landscape of South Korea

With its rapidly growing pharmaceutical industry and stringent regulatory requirements, South Korea is becoming a key global player. But for pharmaceutical companies, navigating this landscape requires strategic planning and compliance expertise.  The Ministry of Food and Drug Safety in South Korea (MFDS), previously known as the Korean Food and Drug Administration, serves as South Korea’s

Navigating the Drug Regulatory Landscape of South Korea Read More »

pharmacovigilance approach for biosimilars market

Pharmacovigilance Approaches for Biosimilars Market Success 

The pharmaceutical field has witnessed a tremendous growth of innovation and success in the past few years. Among these advancements, biosimilars have become essential for improving patient access and reducing the cost of therapies. The complexities that even a slight manufacturing differences can lead to variations in protein structure, post-translational modifications, and glycosylation patterns. Since

Pharmacovigilance Approaches for Biosimilars Market Success  Read More »

Global Cosmetic Regulations A Guide for Cometic Products

Understanding Global Cosmetic Regulatory Standards

The global cosmetic industry is a complex and rapidly growing landscape where regulatory compliance is fundamental in ensuring product safety, efficacy, and market access. As cosmetic products cross borders, manufacturers must comply with country-specific regulations from ingredients safety to product labeling. These regulations protect consumers and set the standards that businesses must follow to enter

Understanding Global Cosmetic Regulatory Standards Read More »

Insights of Vaccine Lifecycle Management

Insights into Vaccine Lifecycle Management

Vaccines are an indispensable element of modern public health, playing an essential role in preventing infectious diseases and saving millions of lives annually. But at the core of any successful immunization campaign is an intricate multi-stage process known as Vaccine Lifecycle Management (VLM). This encompasses everything from early research and development (R&D) through post market

Insights into Vaccine Lifecycle Management Read More »

Outsourcing MAH

How Does Outsourcing MAH Responsibilities Impact a Pharmaceutical Company’s Global Expansion Strategy?

Marketing Authorisation Holder (MAH) refers to a person or company that has been granted permission to market a pharmaceutical product within a specific country. MAHs are subject to a number of regulatory requirements and ensure pharmaceutical products meet stringent safety and quality standards. As regulatory frameworks are becoming more stringent, many companies are turning to

How Does Outsourcing MAH Responsibilities Impact a Pharmaceutical Company’s Global Expansion Strategy? Read More »

Digital Revolution on Pharmaceutical Industry

Impact of the Digital Revolution on Pharmaceutical Industry

The pharmaceutical industry, long characterized by traditional research and manufacturing practices, is currently undergoing a profound revolution. Led by advanced analytics, artificial intelligence (AI), blockchain, and other cutting-edge technologies, digital innovations are revolutionizing drug discovery, manufacturing, marketing patient care services and regulatory oversight, with real world examples and extensive research supporting these changes. This blog

Impact of the Digital Revolution on Pharmaceutical Industry Read More »

Regulatory Compliance Pathway in the Middle East

Insights into the Pharmaceutical Regulatory Framework of the Middle East

Middle Eastern pharmaceutical companies are increasingly prioritizing innovation, amid significant regulatory reforms and harmonization efforts. The region encompassing a diverse range of countries, presents both challenges and opportunities for companies aiming to enter these markets.    In this Blog, we explore the key elements of the evolving regulatory frameworks in middle east.  Fragmented and complex regulatory

Insights into the Pharmaceutical Regulatory Framework of the Middle East Read More »